Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Flavia Palombo is active.

Publication


Featured researches published by Flavia Palombo.


Annals of Neurology | 2016

Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.

Michael G. Ricos; Bree L. Hodgson; Tommaso Pippucci; Akzam Saidin; Yeh Sze Ong; Sarah E. Heron; Laura Licchetta; Francesca Bisulli; Marta A. Bayly; James N. Hughes; Sara Baldassari; Flavia Palombo; Margherita Santucci; Stefano Meletti; Samuel F. Berkovic; Guido Rubboli; Paul Q. Thomas; Ingrid E. Scheffer; Paolo Tinuper; Joel Geoghegan; Andreas W. Schreiber; Leanne M. Dibbens

Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy.


Annals of Neurology | 2015

Mutations in the mTOR pathway regulators NPRL2 and NPRL3 cause focal epilepsy

Michael G. Ricos; Bree L. Hodgson; Tommaso Pippucci; Akzam Saidin; Yeh Sze Ong; Sarah E. Heron; Laura Licchetta; Francesca Bisulli; Marta A. Bayly; James N. Hughes; Sara Baldassari; Flavia Palombo; Margherita Santucci; Stefano Meletti; Samuel F. Berkovic; Guido Rubboli; Paul Q. Thomas; Ingrid E. Scheffer; Paolo Tinuper; Joel Geoghegan; Andreas W. Schreiber; Leanne M. Dibbens

Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy.


Bioinformatics | 2014

H3M2: detection of runs of homozygosity from whole-exome sequencing data

Alberto Magi; Lorenzo Tattini; Flavia Palombo; Matteo Benelli; Alessandro Gialluisi; Betti Giusti; Rosanna Abbate; Marco Seri; Gian Franco Gensini; Giovanni Romeo; Tommaso Pippucci

MOTIVATION Runs of homozygosity (ROH) are sizable chromosomal stretches of homozygous genotypes, ranging in length from tens of kilobases to megabases. ROHs can be relevant for population and medical genetics, playing a role in predisposition to both rare and common disorders. ROHs are commonly detected by single nucleotide polymorphism (SNP) microarrays, but attempts have been made to use whole-exome sequencing (WES) data. Currently available methods developed for the analysis of uniformly spaced SNP-array maps do not fit easily to the analysis of the sparse and non-uniform distribution of the WES target design. RESULTS To meet the need of an approach specifically tailored to WES data, we developed [Formula: see text], an original algorithm based on heterogeneous hidden Markov model that incorporates inter-marker distances to detect ROH from WES data. We evaluated the performance of [Formula: see text] to correctly identify ROHs on synthetic chromosomes and examined its accuracy in detecting ROHs of different length (short, medium and long) from real 1000 genomes project data. [Formula: see text] turned out to be more accurate than GERMLINE and PLINK, two state-of-the-art algorithms, especially in the detection of short and medium ROHs. AVAILABILITY AND IMPLEMENTATION [Formula: see text] is a collection of bash, R and Fortran scripts and codes and is freely available at https://sourceforge.net/projects/h3m2/. CONTACT [email protected] SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.


PLOS ONE | 2013

A Novel Null Homozygous Mutation Confirms CACNA2D2 as a Gene Mutated in Epileptic Encephalopathy

Tommaso Pippucci; Antonia Parmeggiani; Flavia Palombo; Alessandra Maresca; Andrea Angius; Laura Crisponi; Francesco Cucca; Rocco Liguori; Maria Lucia Valentino; Marco Seri; Valerio Carelli

Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding α2δ-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished α2δ-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.


Haematologica | 2016

Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia

Federica Melazzini; Flavia Palombo; Alessandra Balduini; Daniela De Rocco; Caterina Marconi; Patrizia Noris; Chiara Gnan; Tommaso Pippucci; Valeria Bozzi; Michela Faleschini; Serena Barozzi; Michael Doubek; Christian A. Di Buduo; Katerina Stano Kozubik; Lenka Radová; Giuseppe Loffredo; Šárka Pospíšilová; Caterina Alfano; Marco Seri; Carlo L. Balduini; Alessandro Pecci; Anna Savoia

ETV6-related thrombocytopenia is an autosomal dominant thrombocytopenia that has been recently identified in a few families and has been suspected to predispose to hematologic malignancies. To gain further information on this disorder, we searched for ETV6 mutations in the 130 families with inherited thrombocytopenia of unknown origin from our cohort of 274 consecutive pedigrees with familial thrombocytopenia. We identified 20 patients with ETV6-related thrombocytopenia from seven pedigrees. They have five different ETV6 variants, including three novel mutations affecting the highly conserved E26 transformation-specific domain. The relative frequency of ETV6-related thrombocytopenia was 2.6% in the whole case series and 4.6% among the families with known forms of inherited thrombocytopenia. The degree of thrombocytopenia and bleeding tendency of the patients with ETV6-related thrombocytopenia were mild, but four subjects developed B-cell acute lymphoblastic leukemia during childhood, resulting in a significantly higher incidence of this condition compared to that in the general population. Clinical and laboratory findings did not identify any particular defects that could lead to the suspicion of this disorder from the routine diagnostic workup. However, at variance with most inherited thrombocytopenias, platelets were not enlarged. In vitro studies revealed that the maturation of the patients’ megakaryocytes was defective and that the patients have impaired proplatelet formation. Moreover, platelets from patients with ETV6-related thrombocytopenia have reduced ability to spread on fibrinogen. Since the dominant thrombocytopenias due to mutations in RUNX1 and ANKRD26 are also characterized by normal platelet size and predispose to hematologic malignancies, we suggest that screening for ETV6, RUNX1 and ANKRD26 mutations should be performed in all subjects with autosomal dominant thrombocytopenia and normal platelet size.


Neurology Genetics | 2015

Epilepsy with auditory features A heterogeneous clinico-molecular disease

Tommaso Pippucci; Laura Licchetta; Sara Baldassari; Flavia Palombo; Veronica Menghi; Romina D'Aurizio; Chiara Leta; Carlotta Stipa; Giovanni Boero; G. D'Orsi; Alberto Magi; Ingrid E. Scheffer; Marco Seri; Paolo Tinuper; Francesca Bisulli

Objective: To identify novel genes implicated in epilepsy with auditory features (EAF) in phenotypically heterogeneous families with unknown molecular basis. Methods: We identified 15 probands with EAF in whom an LGI1 mutation had been excluded. We performed electroclinical phenotyping on all probands and available affected relatives. We used whole-exome sequencing (WES) in 20 individuals with EAF (including all the probands and 5 relatives) to identify single nucleotide variants, small insertions/deletions, and copy number variants. Results: WES revealed likely pathogenic variants in genes that had not been previously associated with EAF: a CNTNAP2 intragenic deletion, 2 truncating mutations of DEPDC5, and a missense SCN1A change. Conclusions: EAF is a clinically and molecularly heterogeneous disease. The association of EAF with CNTNAP2, DEPDC5, and SCN1A mutations widens the phenotypic spectrum related to these genes. CNTNAP2 encodes CASPR2, a member of the voltage-gated potassium channel complex in which LGI1 plays a role. The finding of a CNTNAP2 deletion emphasizes the importance of this complex in EAF and shows biological convergence.


Thrombosis and Haemostasis | 2016

SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopenia

Caterina Marconi; C. A. Di Buduo; Serena Barozzi; Flavia Palombo; S. Pardini; C. Zaninetti; Tommaso Pippucci; Patrizia Noris; Alessandra Balduini; Marco Seri; Alessandro Pecci

SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopenia -


Embo Molecular Medicine | 2015

Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early‐onset arteriopathy and cavitating leukoencephalopathy

Tommaso Pippucci; Alessandra Maresca; Pamela Magini; Giovanna Cenacchi; Vincenzo Donadio; Flavia Palombo; Valentina Papa; Alex Incensi; Giuseppe Gasparre; Maria Lucia Valentino; Carmela Preziuso; Annalinda Pisano; Michele Ragno; Rocco Liguori; Carla Giordano; Caterina Tonon; Raffaele Lodi; Antonia Parmeggiani; Valerio Carelli; Marco Seri

Notch signaling is essential for vascular physiology. Neomorphic heterozygous mutations in NOTCH3, one of the four human NOTCH receptors, cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Hypomorphic heterozygous alleles have been occasionally described in association with a spectrum of cerebrovascular phenotypes overlapping CADASIL, but their pathogenic potential is unclear. We describe a patient with childhood‐onset arteriopathy, cavitating leukoencephalopathy with cerebral white matter abnormalities presented as diffuse cavitations, multiple lacunar infarctions and disseminated microbleeds. We identified a novel homozygous c.C2898A (p.C966*) null mutation in NOTCH3 abolishing NOTCH3 expression and causing NOTCH3 signaling impairment. NOTCH3 targets acting in the regulation of arterial tone (KCNA5) or expressed in the vasculature (CDH6) were downregulated. Patients vessels were characterized by smooth muscle degeneration as in CADASIL, but without deposition of granular osmiophilic material (GOM), the CADASIL hallmark. The heterozygous parents displayed similar but less dramatic trends in decrease in the expression of NOTCH3 and its targets, as well as in vessel degeneration. This study suggests a functional link between NOTCH3 deficiency and pathogenesis of vascular leukoencephalopathies.


BMC Genomics | 2015

Characterization and identification of hidden rare variants in the human genome

Alberto Magi; Romina D’Aurizio; Flavia Palombo; Ingrid Cifola; Lorenzo Tattini; Roberto Semeraro; Tommaso Pippucci; Betti Giusti; Giovanni Romeo; Rosanna Abbate; Gian Franco Gensini

BackgroundBy examining the genotype calls generated by the 1000 Genomes Project we discovered that the human reference genome GRCh37 contains almost 20,000 loci in which the reference allele has never been observed in healthy individuals and around 70,000 loci in which it has been observed only in the heterozygous state.ResultsWe show that a large fraction of this rare reference allele (RRA) loci belongs to coding, functional and regulatory elements of the genome and could be linked to rare Mendelian disorders as well as cancer. We also demonstrate that classical germline and somatic variant calling tools are not capable to recognize the rare allele when present in these loci. To overcome such limitations, we developed a novel tool, named RAREVATOR, that is able to identify and call the rare allele in these genomic positions. By using a small cancer dataset we compared our tool with two state-of-the-art callers and we found that RAREVATOR identified more than 1,500 germline and 22 somatic RRA variants missed by the two methods and which belong to significantly mutated pathways.ConclusionsThese results show that, to date, the investigation of around 100,000 loci of the human genome has been missed by re-sequencing experiments based on the GRCh37 assembly and that our tool can fill the gap left by other methods. Moreover, the investigation of the latest version of the human reference genome, GRCh38, showed that although the GRC corrected almost all insertions and a small part of SNVs and deletions, a large number of functionally relevant RRAs still remain unchanged. For this reason, also future resequencing experiments, based on GRCh38, will benefit from RAREVATOR analysis results. RAREVATOR is freely available at http://sourceforge.net/projects/rarevator.


American Journal of Medical Genetics Part A | 2016

Prenatal diagnosis of Simpson-Golabi-Behmel syndrome.

Pamela Magini; Flavia Palombo; Simona Boito; Giulia Lanzoni; Patrizia Mongelli; Tommaso Rizzuti; Marco Baccarin; Tommaso Pippucci; Marco Seri; Faustina Lalatta

Simpson–Golabi–Behmel syndrome (SGBS) is an overgrowth syndrome and it is usually diagnosed postnatally, on the basis of phenotype. Prenatal ultrasonography may show fetal alterations, but they are not pathognomonic and most of them are frequently detectable only from the 20th week of gestation. Nevertheless, early diagnosis is important to avoid neonatal complications and make timely and informed decisions about the pregnancy. We report on four fetuses from two unrelated families, in whom the application of whole exome sequencing and array‐CGH allowed the identification of GPC3 alterations causing SGBS. The careful follow up of pregnancies and more sophisticated analysis of ultrasound findings led to the identification of early prenatal alterations, which will improve the antenatal diagnosis of SGBS.

Collaboration


Dive into the Flavia Palombo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge